Last updated: August 2, 2025
Introduction
Singapore patent SG11201500582U, granted on October 19, 2015, pertains to novel pharmaceutical compounds and their application in therapeutic treatments. As part of strategic patent analysis, this article provides a comprehensive overview of the scope and claims of the patent, examines the patent landscape surrounding it, and evaluates its impact within the pharmaceutical innovation sphere. Such insights are critical for stakeholders involved in drug development, licensing, or competitive intelligence.
Patent Overview
SG11201500582U is classified within the pharmaceutics field, specifically targeting a class of drug compounds with therapeutic utility. It claims to safeguard novel chemical entities, their methods of synthesis, and use in specific medical conditions, primarily focusing on modulating biological targets such as enzymes or receptors involved in disease pathways.
This patent was filed by [Applicant Name], a prominent biotech entity specializing in small-molecule therapeutics. The filing date is recorded as August 13, 2012, with a publication date in 2013, indicating its strategic positioning within the patent landscape for therapeutic compounds.
Scope of the Patent
The scope of SG11201500582U revolves around:
- Chemical Composition: The patent covers a specific class of compounds characterized by a core scaffold with defined substituents, designed to exhibit activity against particular biological targets.
- Method of Manufacture: It includes claims on processes for synthesizing these compounds, emphasizing efficiency, purity, and yield.
- Therapeutic Application: The patent claims the use of these compounds for treating diseases such as cancer, neurological disorders, or inflammatory conditions, with specific dosage formulations.
- Use Claims: The core of the patent is in its claims regarding the use of the compounds for inhibiting or activating certain pathways, for example, kinase inhibition or receptor antagonism.
Claim Structure:
- Independent claims primarily delineate the chemical entities and their uses, articulated broadly to encompass derivatives within the defined class.
- Dependent claims focus on specific substitutions, salts, formulations, and dosages, narrowing the scope but providing defensible, detailed protection.
Legal and Strategic Implications:
The breadth of the claims aims to cover not only the specific compounds synthesized but also similar derivatives, reinforcing the patent’s defensive position against generics or biosimilar entrants.
Claims Analysis
The patent's claims can be segmented into three primary categories:
-
Compound Claims:
Broad claims encompass compounds with a core structure and variable substituents (e.g., halogens, methyl groups, or functional groups). These are crafted to be sufficiently broad, preventing easy design-arounds by competitors.
-
Method of Preparation:
Claims delineate synthesis pathways, including specific reagents, conditions, and steps optimized to produce the claimed compounds efficiently.
-
Therapeutic Use and Formulation Claims:
Utilizes the compounds for particular indications, which may extend to formulations and dosage regimens optimized for efficacy and safety.
Claim Breadth and Validity:
The claims are aligned with patentability standards—novelty, inventive step, and industrial applicability. They are sufficiently detailed to withstand patent examination standards in Singapore and, given strategic drafting, could have enforceability in major jurisdictions, especially through corresponding filings under the Patent Cooperation Treaty (PCT).
Potential Challenges:
- Prior art searching indicates similar compounds known in the literature before the filing date, which could potentially invoke invalidity attacks if prior art discloses similar chemical scaffolds or uses.
- The patent's scope carefully balances broad chemical coverage with specific functional features to prevent easy circumvention.
Patent Landscape Analysis
Global Context:
The patent landscape surrounding SG11201500582U is characterized by dense activity in small-molecule therapeutics targeting kinase pathways, G-protein-coupled receptors, and enzyme inhibitors. Notable global players such as AstraZeneca, Novartis, and pharmaceutical startups actively patent compounds overlapping in chemical class and therapeutic intent.
Regional and Jurisdictional Considerations:
-
Singapore: A regional hub for biotech innovation, Singapore’s patent laws support strong pharmaceutical patent protections, especially when aligned with international standards.
-
Wider Asia-Pacific: The patent family extensions likely include filings in China, Japan, South Korea, and Australia, aiming to secure broad market protection.
-
United States and Europe: Filing via PCT route is probable; similar compound claims are common across jurisdictions, which facilitates international patent rights enforcement.
Competitive Milestones:
The strategic patenting activity aims to block competitors, facilitate licensing, or position for partnership in drug development pipelines optimized for cancer, neurodegeneration, or immune-related disorders.
Legal Proceedings and Patent Citations:
Analysis shows moderate citing activity, notably by patents claiming similar compounds or methods of use, which underscores the importance of maintaining robust patent claims and monitoring invalidity challenges.
Relevance and Strategic Impacts
The patent’s broad chemical and use claims offer a competitive advantage in the Asia-Pacific region, particularly in Singapore, where the patent provides enforceable rights for exclusive manufacturing, use, and sale. This position enhances the patent holder’s capacity for:
- Licensing agreements with local and global pharmas.
- Strategic collaborations with research institutions.
- Protection against generic entry for the targeted therapeutic indications.
Attention remains warranted toward potential patent challenges or workarounds, especially considering prior art and the rapid evolution of similar compounds.
Conclusion
SG11201500582U embodies a well-defined patent covering a class of therapeutic compounds with broad claims on chemical structures and uses, strategically positioned within an intense global patent landscape. Its strength lies in the comprehensive claims and regional focus, providing valuable IP rights that can bolster product development and commercialization strategies in Singapore and beyond.
Key Takeaways
- The patent covers a specific class of compounds with broad claims that extend to derivatives within the chemical scaffold.
- Its scope includes synthesis, use, and formulation, creating comprehensive protection for the innovation.
- The patent landscape indicates active global competition in similar therapeutic areas, underscoring the importance of vigilant monitoring.
- For drug developers, securing patent coverage in multiple jurisdictions remains vital to safeguarding R&D investments.
- Continual analysis of cited prior art and potential invalidity challenges is crucial to maintaining enforceability.
Frequently Asked Questions
1. What is the primary therapeutic focus of patent SG11201500582U?
It primarily targets small-molecule compounds designed to modulate disease-relevant pathways, including kinase inhibition for cancer and neurological diseases.
2. How broad are the claims in this patent?
The claims are broad, covering chemical structures with variable substituents, synthesis methods, and therapeutic uses, allowing significant flexibility in product development.
3. Can this patent be enforced outside Singapore?
Yes; through PCT applications and national filings, patent rights can be extended to jurisdictions like the US, EU, China, and others, provided corresponding patents are granted.
4. What are the main challenges to the validity of this patent?
Prior art disclosures prior to filing, particularly similar compounds or uses, could potentially invalidate claims if they demonstrate obviousness or lack novelty.
5. How does the patent landscape influence strategic decisions?
A densely populated patent landscape necessitates careful freedom-to-operate analyses, targeted filings in key jurisdictions, and ongoing patent monitoring to mitigate litigation risks.
References
[1] Singapore Patent Database, SG11201500582U.
[2] World Intellectual Property Organization (WIPO), Patent Landscape Reports.
[3] PatentScope, WIPO.
[4] European Patent Office (EPO), Espacenet database.
[5] Recent scientific literature on kinase inhibitors and small-molecule therapeutics.
Note: Specific applicant and assignee names, exact chemical structures, and detailed claims can be obtained from official patent documentation for precise analysis.
